NAXBYIN

Serial Number 87312002
606

Registration Progress

Application Filed
Jan 24, 2017
Under Examination
Jul 25, 2017
Approved for Publication
May 30, 2017
Published for Opposition
May 30, 2017
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NAXBYIN
Previous Owner: Amphastar Pharmaceuticals, Inc.
Classes: 005

Trademark Image

NAXBYIN

Basic Information

Serial Number
87312002
Filing Date
January 24, 2017
Published for Opposition
May 30, 2017
Abandonment Date
August 31, 2020
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Aug 31, 2020
Classes
005

Rights Holder

Amphastar Pharmaceuticals, Inc.

03
Address
11570 Sixth Street
Rancho Cucamonga, CA 91730

Ownership History

Amphastar Pharmaceuticals, Inc.

Original Applicant
03
Rancho Cucamonga, CA

Amphastar Pharmaceuticals, Inc.

Owner at Publication
03
Rancho Cucamonga, CA

Legal Representation

Attorney
Lesley Y. Kim

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

33 events
Date Code Type Description Documents
Aug 31, 2020 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Aug 31, 2020 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Dec 3, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 2, 2019 EX5G S SOU EXTENSION 5 GRANTED Loading...
Nov 22, 2019 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 2, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 22, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 19, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 17, 2019 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 17, 2019 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 17, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 9, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 7, 2019 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jan 7, 2019 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 7, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 7, 2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 7, 2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 4, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 2, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jul 2, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 19, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 17, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jan 17, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
Jan 17, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 25, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
May 30, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
May 30, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 10, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 17, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 13, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 28, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 27, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical and drug preparations for use in treatment of opioid overdose and addiction; Medicinal preparations for use in treatment of opioid overdose and addiction; Pharmaceutical and drug preparations for the treatment of substance use disorders, addiction, and overdose; Medicinal preparations for the treatment of substance use disorders, addiction, and overdose; Pharmaceutical preparations, namely, opioid antagonists; pharmaceutical preparations, namely, pharmaceuticals which contain the compound naloxone for the treatment of complete or partial reversal of opioid depression, including respiratory depression, induced by natural and synthetic opioids; Pharmaceutical and drug preparations for use in complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics

Classification

International Classes
005